SIGA Technologies Inc. (SIGA) News

SIGA Technologies Inc. (SIGA): $7.33

-0.05 (-0.68%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SIGA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 492

in industry

Filter SIGA News Items

SIGA News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

SIGA News Highlights

  • SIGA's 30 day story count now stands at 3.
  • Over the past 5 days, the trend for SIGA's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about SIGA are ID, MSCI and ST.

Latest SIGA News From Around the Web

Below are the latest news stories about Siga Technologies Inc that investors may wish to consider to help them evaluate SIGA as an investment opportunity.

Should You Consider Investing in SIGA Technologies (SIGA)?

Steel City Capital LP, an investment management firm, published its first quarter 2021 investor letter – a copy of which can be downloaded here. A net return of 7.6% was delivered by the fund for the Q1 of 2021, above the S&P 500 and MSCI All World Index that delivered a 5.8% and 4.8% returns respectively, […]

Yahoo | May 3, 2021

SIGA Technologies to Host Business Update Call on May 6th, 2021 Following Release of First Quarter 2021 Financial Results

NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, May 6, 2021. Participating on the call will be Dr. Phil Gomez, Chief Executive Officer and Daniel Luckshire, Chief Financial Officer. A live webcast of the call will also be available on the Company's website at www.siga.com under the 'Events & Presentations' tab in the Investor Relations section, or by clicking here. Please log in approximately 5-10 minutes prior to the scheduled start time. Participants may access the call by dialing 1-800-891-3448 for domestic callers or 1-416-641-6700 for international callers. A replay of...

Yahoo | April 29, 2021

SIGA Technologies: Biodefense Pharma Unlocks New Value Abroad For TPOXX

Photo by SrdjanPav/E+ via Getty Images Graphic Source: SIGA Technologies, Inc. Introduction: What is SIGA Technologies? SIGA Technologies, Inc. (NASDAQ: SIGA) is a commercial-stage pharmaceutical company developing drugs for health security and infectious diseases globally. SIGA's lead therapeutic is an oral antiviral drug approved by the FDA for treating human...

Gunner Laine Hardy on Seeking Alpha | April 28, 2021

SIGA Technologies, Inc.'s (NASDAQ:SIGA) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?

SIGA Technologies (NASDAQ:SIGA) has had a rough three months with its share price down 11%. However, a closer look at...

Yahoo | April 1, 2021

Cipla Therapeutics and SIGA Technologies Announce Strategic Partnership to support innovation and provide access to novel antibacterial drugs against biothreats

NEW YORK, March 23, 2021 (GLOBE NEWSWIRE) -- Cipla Therapeutics, a division of Cipla USA Inc., an affiliate of Cipla Limited (BSE: 500087; NSE: CIPLA EQ; referred to as "Cipla") and SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market announced entering into a strategic partnership to deliver sustained innovation and access to novel antibacterial drugs, particularly against biothreats. The World Health Organization has declared that anti-microbial resistance (AMR) one of the top 10 global public health threats facing humanity2 which puts at risk the effective prevention and treatment of a wide range of infections. According to the AMR Industry Alliance, a global AMR private sector coalition, AMR is the ability of ...

Yahoo | March 23, 2021

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2020

- Approximately 363,000 Courses of Oral TPOXX® Delivered to U.S. Government in 2020 – - International Contracts for the Purchase of up to Approximately $47 Million of Oral TPOXX® Since April 2020 – - Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, March 04, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today reported financial results for the three and twelve months ended December 31, 2020. “SIGA’s fourth quarter and annual financial results are highlighted by the delivery of approximately 112,000 and 363,000 courses, respectively, of oral TPOXX® to the U.S. strategic national stockpile (SNS), generating revenue from these deliveries of approximately $35 million and $113 million, respectively,” said Ph...

Yahoo | March 4, 2021

SIGA Technologies, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 4, 2021 / SIGA Technologies, Inc. (NASDAQ:SIGA) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 4, 2021 at 4:30 PM Eastern Time.

Yahoo | March 4, 2021

SIGA Technologies to Host Business Update Call on March 4, 2021 Following Release of Year End 2020 Financial Results

NEW YORK, Feb. 26, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that management will host a webcast and conference call to provide a business update at 4:30 P.M. ET on Thursday, March 4, 2021. Participating on the call will be Dr. Phil Gomez, Chief Executive Officer, Daniel Luckshire, Chief Financial Officer, and Dr. Dennis Hruby, Chief Scientific Officer. A live webcast of the call will be available on the Company's website at www.siga.com under the 'Events & Presentations' tab in the Investor Relations section, or by clicking here. Participants may also access the call by dialing 877-407-6184 for domestic callers or 201-389-0877 for international callers. Please ...

Yahoo | February 26, 2021

SIGA Announces Public Health Agency of Canada Contract Award to Purchase Up To Approximately $33 Million of Oral TPOXX®

Second Contract by a Canadian Governmental Agency for the Procurement of Oral TPOXXNEW YORK, Jan. 13, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the Public Health Agency of Canada (PHAC) has awarded a contract to Meridian Medical Technologies, Inc. (“Meridian”, a Pfizer Company) (the “Contract”) for the purchase up to approximately $33 million of oral TPOXX® (tecovirimat) within five years. The Contract specifies firm commitments for the purchase of approximately $3.4 million of oral TPOXX by March 31, 2021 and a cumulative purchase of approximately $17.2 million of oral TPOXX by March 31, 2023; the remaining courses under the Contract are scheduled to be pu...

Yahoo | January 13, 2021

SIGA Reports Financial Results for Three and Nine Months Ended September 30, 2020

\- Third Quarter includes Delivery of Approximately 134,000 Courses of TPOXX® to U.S. Government – \- In October, the Public Health Agency of Canada Announced its Intent to Purchase up to 33,300 Courses of Oral TPOXX® – \- Corporate Update Conference Call Today at 4:30 PM ET -NEW YORK, Nov. 05, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today reported financial results for the three and nine months ended September 30, 2020. “SIGA’s third quarter was highlighted by the delivery of approximately 134,000 courses of oral TPOXX® to the strategic national stockpile (SNS),” said Phil Gomez, CEO of SIGA. “With deliveries made in the second quarter, SIGA has delivered approximately 251...

Yahoo | November 5, 2020


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6343 seconds.